Aberrant <scp>TIMP</scp>‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in...
Project: StretchBio
Updated at: 01-02-2025
Project: StretchBio
Updated at: 01-02-2025
Project: StretchBio
Updated at: 01-02-2025
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 24-07-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024
Project: StretchBio
Updated at: 27-04-2024